Cenra Inc. (TPE:3716)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.25
+0.30 (0.86%)
At close: Jun 24, 2026
Market Cap5.11B -9.2%
Revenue (ttm)8.54B -3.9%
Net Income377.97M +14.7%
EPS3.01 +11.8%
Shares Out 146.14M
PE Ratio11.63
Forward PEn/a
Dividend1.00 (2.84%)
Ex-Dividend Daten/a
Volume217,405
Open35.00
Previous Close34.95
Day's Range34.85 - 35.40
52-Week Range31.55 - 36.90
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for pres... [Read more]

Sector Healthcare
Founded 2024
Employees 542
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3716
Full Company Profile

Financial Performance

In 2025, Cenra's revenue was 8.57 billion, a decrease of -3.91% compared to the previous year's 8.92 billion. Earnings were 300.07 million, a decrease of -5.44%.

Financial Statements